ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-11 |

Results: 11

Time trends in the coprescribing of cisapride and contraindicated drugs inUmbria, Italy

Authors: Raschetti, R Maggini, M Da Cas, R Popoli, P Rossi, A

Citation: R. Raschetti et al., Time trends in the coprescribing of cisapride and contraindicated drugs inUmbria, Italy, J AM MED A, 285(14), 2001, pp. 1840-1841

Active monitoring of adverse drug reactions in children

Authors: Menniti-Ippolito, F Raschetti, R Da Cas, R Giaquinto, C Cantarutti, L

Citation: F. Menniti-ippolito et al., Active monitoring of adverse drug reactions in children, LANCET, 355(9215), 2000, pp. 1613-1614

Criticism ignores standard methodology of cancer treatments

Authors: Raschetti, R Greco, D Menniti-Ippolito, F Spila-Alegiani, S Traversa, G Benagiano, G Bruzzi, P

Citation: R. Raschetti et al., Criticism ignores standard methodology of cancer treatments, BR MED J, 318(7190), 1999, pp. 1074-1074

Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy

Authors: Raschetti, R

Citation: R. Raschetti, Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy, BR MED J, 318(7178), 1999, pp. 224-228

Reactogenicity in the elderly of nine commercial influenza vaccines: results from the Italian SVEVA study

Authors: Spila-Alegiani, S Salmaso, S Rota, MC Tozzi, AE Raschetti, R

Citation: S. Spila-alegiani et al., Reactogenicity in the elderly of nine commercial influenza vaccines: results from the Italian SVEVA study, VACCINE, 17(15-16), 1999, pp. 1898-1904

Methodological and ethical difficulties in clinical oncology trials

Authors: Raschetti, R Bruni, P

Citation: R. Raschetti et P. Bruni, Methodological and ethical difficulties in clinical oncology trials, LANCET, 353(9147), 1999, pp. 153-154

To the letter to the editors by S. Erny and H. Maradit. Outpatient use pattern for ketorolac is distinct from comparator drugs - Reply

Authors: Menniti-Ippolito, F Maggini, M Raschetti, R Da Cas, R Traversa, G Walker, AM

Citation: F. Menniti-ippolito et al., To the letter to the editors by S. Erny and H. Maradit. Outpatient use pattern for ketorolac is distinct from comparator drugs - Reply, EUR J CL PH, 55(1), 1999, pp. 83-83

Suspected adverse drug events requiring emergency department visits or hospital admissions

Authors: Raschetti, R Morgutti, M Menniti-Ippolito, F Belisari, A Rossignoli, A Longhini, P La Guidara, C

Citation: R. Raschetti et al., Suspected adverse drug events requiring emergency department visits or hospital admissions, EUR J CL PH, 54(12), 1999, pp. 959-963

Mortality cancer risk in parkinsonian patients: A population-based study -Reply

Authors: Vanacore, N Spila-Alegiani, S Raschetti, R Meco, G

Citation: N. Vanacore et al., Mortality cancer risk in parkinsonian patients: A population-based study -Reply, NEUROLOGY, 53(5), 1999, pp. 1159-1159

Mortality cancer risk in parkinsonian patients: A population-based study

Authors: Vanacore, N Spila-Alegiani, S Raschetti, R Meco, G

Citation: N. Vanacore et al., Mortality cancer risk in parkinsonian patients: A population-based study, NEUROLOGY, 52(2), 1999, pp. 395-398

The unconventional Di Bella cancer treatment - A reflection on the Italianexperience

Authors: Traversa, G Maggini, M Menniti-Ippolito, F Bruzzi, P Chiarotti, F Greco, D Spila-Alegiani, S Raschetti, R Benagiano, G

Citation: G. Traversa et al., The unconventional Di Bella cancer treatment - A reflection on the Italianexperience, CANCER, 86(10), 1999, pp. 1903-1911

Risultati: 1-11 |